SIT INVESTMENT ASSOCIATES INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 769317
Minneapolis, MN
Position in SUPN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,557,564
+$317,124 QoQ
Shares Held
68,825
+5.6% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SIT INVESTMENT ASSOCIATES INC holds $4,458,474 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (79.8% of the industry book) .
All Filings in SUPN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,557,564 | 68,825 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,240,440 | 65,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,103,960 | 64,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,047,224 | 64,950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,270,700 | 38,800 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,403,008 | 38,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,209,784 | 38,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,037,900 | 38,800 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,323,468 | 38,800 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $273,483 | 9,450 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||